Orapi Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Orapi's earnings have been declining at an average annual rate of -76.2%, while the Chemicals industry saw earnings growing at 7.4% annually. Revenues have been declining at an average rate of 2.6% per year.
Información clave
-76.2%
Tasa de crecimiento de los beneficios
-72.9%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 10.4% |
| Tasa de crecimiento de los ingresos | -2.6% |
| Rentabilidad financiera | -90.5% |
| Margen neto | -11.8% |
| Última actualización de beneficios | 30 Jun 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Orapi (EPA:ORAP) Is Reinvesting At Lower Rates Of Return
Aug 09
Investors Still Waiting For A Pull Back In Orapi SA (EPA:ORAP)
Jun 13Calculating The Fair Value Of Orapi SA (EPA:ORAP)
Mar 30A Look At The Fair Value Of Orapi SA (EPA:ORAP)
Nov 17Orapi (EPA:ORAP) Might Have The Makings Of A Multi-Bagger
Aug 22Calculating The Fair Value Of Orapi SA (EPA:ORAP)
Jun 30Is Orapi (EPA:ORAP) A Risky Investment?
May 20Returns At Orapi (EPA:ORAP) Are On The Way Up
Mar 15Orapi (EPA:ORAP) Has A Somewhat Strained Balance Sheet
Nov 17Orapi's (EPA:ORAP) Earnings Are Of Questionable Quality
Apr 25Is Orapi (EPA:ORAP) A Risky Investment?
Apr 19Does Orapi (EPA:ORAP) Have The DNA Of A Multi-Bagger?
Feb 23Is Orapi SA's (EPA:ORAP) ROE Of 0.8% Concerning?
Jan 19
We Think Orapi (EPA:ORAP) Is Taking Some Risk With Its Debt
Dec 15Desglose de ingresos y gastos
Cómo gana y gasta dinero Orapi. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Jun 24 | 226 | -27 | 90 | 0 |
| 31 Mar 24 | 227 | -23 | 88 | 0 |
| 31 Dec 23 | 229 | -19 | 87 | 0 |
| 30 Jun 23 | 232 | -7 | 90 | 0 |
| 31 Mar 23 | 231 | -3 | 90 | 0 |
| 31 Dec 22 | 227 | 1 | 89 | 0 |
| 30 Jun 22 | 228 | 0 | 93 | 0 |
| 31 Mar 22 | 227 | 0 | 93 | 0 |
| 31 Dec 21 | 227 | 0 | 93 | 0 |
| 30 Sep 21 | 236 | 2 | 97 | 0 |
| 30 Jun 21 | 245 | 3 | 101 | 0 |
| 31 Mar 21 | 256 | 6 | 103 | 0 |
| 31 Dec 20 | 268 | 9 | 105 | 0 |
| 30 Sep 20 | 260 | 5 | 101 | 0 |
| 30 Jun 20 | 252 | 0 | 97 | 0 |
| 31 Mar 20 | 246 | -1 | 97 | 0 |
| 31 Dec 19 | 240 | -3 | 97 | 0 |
| 30 Sep 19 | 247 | 0 | 101 | 0 |
| 30 Jun 19 | 254 | 3 | 105 | 0 |
| 31 Mar 19 | 255 | 0 | 108 | 0 |
| 31 Dec 18 | 256 | -4 | 110 | 0 |
| 30 Sep 18 | 251 | -4 | 110 | 0 |
| 30 Jun 18 | 247 | -4 | 109 | 0 |
| 31 Mar 18 | 245 | -3 | 109 | 0 |
| 31 Dec 17 | 244 | -2 | 109 | 0 |
| 30 Sep 17 | 243 | -1 | 109 | 0 |
| 30 Jun 17 | 242 | 0 | 109 | 0 |
| 31 Mar 17 | 245 | -1 | 111 | 0 |
| 31 Dec 16 | 248 | -1 | 113 | 0 |
| 30 Sep 16 | 255 | -3 | 116 | 0 |
| 30 Jun 16 | 263 | -4 | 119 | 0 |
| 31 Mar 16 | 270 | -5 | 122 | 0 |
| 31 Dec 15 | 277 | -6 | 126 | 0 |
| 30 Sep 15 | 265 | -3 | 121 | 0 |
| 30 Jun 15 | 252 | -1 | 116 | 0 |
| 31 Mar 15 | 236 | 0 | 110 | 0 |
| 31 Dec 14 | 220 | 2 | 105 | 0 |
| 30 Sep 14 | 220 | 2 | 105 | 0 |
| 30 Jun 14 | 221 | 2 | 105 | 0 |
| 31 Mar 14 | 216 | 3 | 103 | 0 |
| 31 Dec 13 | 211 | 3 | 101 | 0 |
Ingresos de calidad: ORAP is currently unprofitable.
Margen de beneficios creciente: ORAP is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: ORAP is unprofitable, and losses have increased over the past 5 years at a rate of 76.2% per year.
Acelerando crecimiento: Unable to compare ORAP's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: ORAP is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-17.8%).
Rentabilidad financiera
Alta ROE: ORAP has a negative Return on Equity (-90.53%), as it is currently unprofitable.